About Company
SonoChem Limited has acquired, developed and patented (EU and USA), unique antibacterial and antiviral technologies relating to Anti Microbial Resistance (AMR) and Hospital Acquired Infections (HAI).The patents resulted from a major US$12 million European Union-funded seven nation programme ("SONO"), in coordination with Coventry University (UK). SonoChem refined a method for mass producing low cost antimicrobial textiles using Sonochemistry to produce
SonoChem Limited has acquired, developed and patented (EU and USA), unique antibacterial and antiviral technologies relating to Anti Microbial Resistance (AMR) and Hospital Acquired Infections (HAI).The patents resulted from a major US$12 million European Union-funded seven nation programme ("SONO"), in coordination with Coventry University (UK). SonoChem refined a method for mass producing low cost antimicrobial textiles using Sonochemistry to produce nanoparticles, including copper and zinc, for infusion into textiles.
